Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Patrick Soon-Shiong / United States — Food and Drug Administration

Patrick Soon-Shiong & United States — Food and Drug Administration

2 shared events · Importance 3 · Last updated May 09, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
-40.0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (2)
87
Regulatory
ImmunityBio Faces Anktiva Misleading Claims Lawsuit
Patrick Soon-Shiong: Patrick Soon-Shiong, executive chairman and Chief Scientific and Medical Officer of ImmunityBio, is accused of materially overstating Anktiva's capabilities, leading to the lawsuit.
United States — Food and Drug Administration: The United States — Food and Drug Administration sent a warning letter to ImmunityBio regarding misleading efficacy claims made about Anktiva, which triggered the class action lawsuits.
Apr 02, 2026 · 42 articles
0
Regulatory
ImmunityBio Faces Securities Class Actions
Apr 01, 2026 · 45 articles
NEWSDESK
Explore this relationship live

Track how Patrick Soon-Shiong and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.